ValuentumAd

Official PayPal Seal













Fundamental data is updated weekly, as of the prior weekend. Please download the Full Report and Dividend Report for any changes.
Jul 29, 2025
UnitedHealth Group’s Restored 2025 Outlook Falls Below Consensus Estimates
Image Source: TradingView. The new outlook for UnitedHealth Group reflects higher realized and anticipated care trends, but the insurance giant expects to return to earnings growth in 2026. UnitedHealth is contending with rising costs and an investigation from the DOJ related to its Medicare business. We expect to lower our fair value estimate of UnitedHealth Group upon its next update, but we continue to include shares in the newsletter portfolios.
Jul 29, 2025
Waste Management Grows Adjusted Operating EBITDA Double Digits in Second Quarter
Image Source: TradingView. Through the first six months of the year, Waste Management generated $2.75 billion of net cash provided by operating activities, with free cash flow for the first half of the year coming in at $1.29 billion. Looking to all of 2025, management affirmed its adjusted operating EBITDA guidance midpoint of $7.55 billion, while it raised its free cash flow guidance by $125 million, to the range of $2.8-$2.9 billion. Total company revenue is targeted in the range of $25.275-$25.475 billion for the full year, with an adjusted operating EBITDA margin now expected in the range of 29.6%-29.9%, a modest increase from prior guidance. Waste Management is on track to achieve the upper end of its targeted synergies related to WM Health Solutions of $80-$100 million in 2025. We like Waste Management, but don’t include shares in any newsletter portfolio.
Jul 25, 2025
Dividend Increases/Decreases for the Week of July 25
Let's take a look at firms raising/lowering their dividends this week.
Jul 24, 2025
Chipotle Now Expects Flat Comps for 2025
Image Source: Valuentum. Looking to 2025, Chipotle now expects flat full year comparable restaurant sales (was low to mid-single digits) and plans to open 315-345 new company-owned restaurants with over 80% having a Chipotlane. We like Chipotle’s long-term restaurant growth potential and believe its negative comps registered in the second quarter are temporary. Shares remain an idea in the Best Ideas Newsletter portfolio.
Jul 24, 2025
Alphabet Puts Up Excellent Second Quarter Results
Image Source: TradingView. In Alphabet’s second quarter, total operating income increased 14%, as its operating margin came in at 32.4% benefiting from strength in the top line and “continued efficiencies in the expense base." Net income increased to $28.2 billion, up from $23.6 billion in the same quarter of 2024, while diluted earnings per share increased to $2.31 from $1.89 in the year-ago period. Alphabet ended the quarter with $95.1 billion in total cash and marketable securities and long-term debt of $23.6 billion. Through the first six months of the year, free cash flow was $24.3 billion. We like Alphabet as one of the top ideas in the Best Ideas Newsletter portfolio.
Jul 23, 2025
Philip Morris’ Smoke-Free Portfolio Continues to Gain Traction
Image Source: TradingView. Looking to 2025, Philip Morris is targeting reported diluted earnings per share in the range of $7.24-$7.37 versus $4.52 last year. Adjusted diluted earnings per share is expected in the range of $7.43-$7.56 versus $6.57 last year. Adjusted diluted earnings per share, excluding currency, is budgeted in the range of $7.33-$7.46 versus $6.57 last year. In the second quarter, Philip Morris’ smoke-free business accounted for 41% of total net revenue, as it continues to benefit in part from rampant ZYN adoption. In the U.S., “ZYN reaccelerated its offtake growth to approximately 36% in June, and 26% in Q2 overall as measured by Nielsen." We continue to like Philip Morris’ smoke-free business and have no qualms with it as a idea in the High Yield Dividend Newsletter portfolio.
Jul 23, 2025
Lockheed Martin Announces Program Losses
Image Source: TradingView. Looking to 2025, Lockheed Martin reiterated its sales guidance in the range of $73.75-$74.75 billion, but it cut its business segment operating profit expectations for the year to the range of $6.6-$6.7 billion from $8.1-$8.2 billion. Diluted earnings per share for 2025 is now expected in the range of $21.70-$22.00, down from the range of $27.00-$27.30 previously. Lockheed maintained its cash flow from operations guidance for 2025 in the range of $8.5-$8.7 billion. It also maintained its free cash flow guidance for the year in the range of $6.6-$6.8 billion. We didn’t like the announced pre-tax losses on programs but were encouraged that Lockheed stuck with its annual free cash flow outlook. Lockheed Martin remains an idea in the Dividend Growth Newsletter portfolio.
Jul 20, 2025
Kinder Morgan Expected to Capitalize on Natural Gas Demand
Image Source: TradingView. Looking to 2025, Kinder Morgan expects net income to be $2.8 billion, up 8% when compared to last year’s tally. Adjusted earnings per share is targeted at $1.27, which is 10% better than the mark achieved in 2024. Kinder Morgan expects to declare dividends of $1.17 per share for 2025, which represents an increase of 2% from dividends declared in 2024. Finally, the pipeline giant has budgeted 2025 adjusted EBITDA of $8.3 billion, up 4% versus 2024, while it plans to end 2025 with a net debt-to-adjusted EBITDA ratio of 3.8 times. We like Kinder Morgan, but don’t include shares in any newsletter portfolio.
Jul 20, 2025
Johnson & Johnson Raises 2025 Guidance
Image Source: J&J. Looking to all of 2025, J&J raised its adjusted operational sales growth target to the range of 3.2%-3.7%, up from 2%-3% previously. Adjusted operational earnings per share for the year is expected in the range of $10.63-$10.73, up from $10.50-$10.70 previously, implying growth of 6.5%-7.5% versus the prior year. In the press release, management noted “significant new product pipeline progress including approval of IMAAVY for generalized myasthenia gravis, priority review for TAR-200, data for CARVYKTI overall survival and progression-free benefits in multiple myeloma, and continuation of the clinical trial for a general surgery robotic system, OTTAVA.”  We like J&J, but don’t include shares in any newsletter portfolio.
Jul 18, 2025
Dividend Increases/Decreases for the Week of July 18
Let's take a look at firms raising/lowering their dividends this week.


The High Yield Dividend Newsletter, Best Ideas Newsletter, Dividend Growth Newsletter, Nelson Exclusive publication, and any reports, articles and content found on this website are for information purposes only and should not be considered a solicitation to buy or sell any security. The sources of the data used on this website are believed by Valuentum to be reliable, but the data’s accuracy, completeness or interpretation cannot be guaranteed. Valuentum is not responsible for any errors or omissions or for results obtained from the use of its newsletters, reports, commentary, or publications and accepts no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a registered investment advisor and does not offer brokerage or investment banking services. Valuentum, its employees, and affiliates may have long, short or derivative positions in the stock or stocks mentioned on this site.